Filed: 5/15/2025ACC: 0001011438-25-000318
📋 What this filing means
INDABA CAPITAL MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $166.60M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$166.60M
Total AUM (reported)
153.47M
Total Shares
Allocation by class
COM$38.34M23.0%
NOTE 0.500% 4/0$32.48M19.5%
NOTE 1.500% 2/1$27.79M16.7%
NOTE 5.000%12/1$18.52M11.1%
NOTE 1.500% 6/1$15.08M9.1%
COM SH BEN INT$13.53M8.1%
NOTE 2.500% 9/1$12.78M7.7%
Portfolio Concentration
Top 3$82.32M49.4%
4–10$79.96M48.0%
11–25$4.31M2.6%
Top 3 weight
49.4%
Top 10 weight
97.4%
Voting Authority Distribution
Total shares with voting rights: 153.47M
Sole
Full voting authority
153.47M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
BANDWIDTH INC
SOLEShares40.25M
TypePRN
Market value$32.48M
19.50%
Sole
40.25M
Shared
0.00
None
0.00
SUMMIT HOTEL PPTYS
SOLEShares29.04M
TypePRN
Market value$27.79M
16.68%
Sole
29.04M
Shared
0.00
None
0.00
ON24 INC
SOLEShares4.24M
TypeSH
Market value$22.05M
13.23%
Sole
4.24M
Shared
0.00
None
0.00
ACCELERATE DIAGNOSTICS INC
SOLEShares37.05M
TypePRN
Market value$18.52M
11.12%
Sole
37.05M
Shared
0.00
None
0.00
IRONWOOD PHARMACEUTICALS INC
SOLEShares17M
TypePRN
Market value$15.08M
9.05%
Sole
17M
Shared
0.00
None
0.00
EQUITY COMWLTH
SOLEShares8.40M
TypeSH
Market value$13.53M
8.12%
Sole
8.40M
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares13M
TypePRN
Market value$12.78M
7.67%
Sole
13M
Shared
0.00
None
0.00
BLACKBAUD INC
SOLEShares193K
TypeSH
Market value$11.98M
7.19%
Sole
193K
Shared
0.00
None
0.00
ESPERION THERAPEUTICS INC NE
SOLEShares3M
TypeSH
Market value$4.32M
2.59%
Sole
3M
Shared
0.00
None
0.00
ATLANTA BRAVES HLDGS INC
SOLEShares93.81K
TypeSH
Market value$3.75M
2.25%
Sole
93.81K
Shared
0.00
None
0.00
EMBECTA CORP
SOLEShares221.94K
TypeSH
Market value$2.83M
1.70%
Sole
221.94K
Shared
0.00
None
0.00
ADVANTAGE SOLUTIONS INC
SOLEShares980.87K
TypeSH
Market value$1.48M
0.89%
Sole
980.87K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BANDWIDTH INCSOLE | NOTE 0.500% 4/0 | 40.25M | PRN | $32.48M 19.50% | 40.25M | 0.00 | 0.00 |
SUMMIT HOTEL PPTYSSOLE | NOTE 1.500% 2/1 | 29.04M | PRN | $27.79M 16.68% | 29.04M | 0.00 | 0.00 |
ON24 INCSOLE | COM | 4.24M | SH | $22.05M 13.23% | 4.24M | 0.00 | 0.00 |
ACCELERATE DIAGNOSTICS INCSOLE | NOTE 5.000%12/1 | 37.05M | PRN | $18.52M 11.12% | 37.05M | 0.00 | 0.00 |
IRONWOOD PHARMACEUTICALS INCSOLE | NOTE 1.500% 6/1 | 17M | PRN | $15.08M 9.05% | 17M | 0.00 | 0.00 |
EQUITY COMWLTHSOLE | COM SH BEN INT | 8.40M | SH | $13.53M 8.12% | 8.40M | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | NOTE 2.500% 9/1 | 13M | PRN | $12.78M 7.67% | 13M | 0.00 | 0.00 |
BLACKBAUD INCSOLE | COM | 193K | SH | $11.98M 7.19% | 193K | 0.00 | 0.00 |
ESPERION THERAPEUTICS INC NESOLE | COM | 3M | SH | $4.32M 2.59% | 3M | 0.00 | 0.00 |
ATLANTA BRAVES HLDGS INCSOLE | COM SER C | 93.81K | SH | $3.75M 2.25% | 93.81K | 0.00 | 0.00 |
EMBECTA CORPSOLE | COMMON STOCK | 221.94K | SH | $2.83M 1.70% | 221.94K | 0.00 | 0.00 |
ADVANTAGE SOLUTIONS INCSOLE | COM CL A | 980.87K | SH | $1.48M 0.89% | 980.87K | 0.00 | 0.00 |